mIDH1-mutated AML: ivosidenib in clinical practice
This Servier arranged webinar is for hematologists. The agenda for the webinar is: 12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier 12:05-12:30 – Prof. Dr. Michael Heuser - Will present the AGILE study and the clinical implications of the study results. 12:30-12:45 – Docent Vladimir Lazarevic - Focusing on treatment of mIDH1 AML patients […]